Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials

Published:2017-06-30 Issue:42 Volume:8 Page:72950-72958
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Yun¹,Ye Guoxin²,Yan Dali¹,Zhang Lei³,Fan Fan⁴,Feng Jifeng¹

Affiliation:

1. Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing 210009, China

2. Division of Nephrology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China

3. Department of General Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing 210009, China

4. Department of Medical Oncology, No.2 Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of nanocarriers for treatment of urologic cancers;Urologic Oncology: Seminars and Original Investigations;2023-12

2. The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions;Journal of Clinical Medicine;2023-09-16

3. Toxicity of Nab-Paclitaxel Compared to Paclitaxel in a Tertiary Hospital in Jeddah, Saudi Arabia: A Retrospective Cohort Study;Cureus;2023-06-02

4. Neurotoxicity induced by taxane-derived drugs: analysis of the FAERS database 2017–2021;Expert Opinion on Drug Safety;2023-03-30

5. Nanoparticles: Attractive tools to treat colorectal cancer;Seminars in Cancer Biology;2022-11